LIXTE BIOTECHNOLOGY FILES 8-K REPORT
Ticker: LIXT · Form: 8-K · Filed: Feb 25, 2025 · CIK: 1335105
Sentiment: neutral
Topics: 8-K, SEC Filing, Financials
Related Tickers: LIXT
TL;DR
LIXT filed an 8-K on Feb 25, 2025. Check for updates.
AI Summary
On February 25, 2025, LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific financial figures or new material events were detailed in the provided text snippet.
Why It Matters
This filing signals that Lixte Biotechnology has made official disclosures to the SEC, which could contain important updates for investors regarding the company's financial health or significant business developments.
Risk Assessment
Risk Level: low — The filing is a standard procedural disclosure (8-K) without immediate, specific negative or positive financial impacts detailed in the provided text.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Filer of the 8-K report
- February 25, 2025 (date) — Date of the earliest event reported and filing date
- 001-39717 (company) — SEC File Number for Lixte Biotechnology
- 20-2903526 (company) — IRS Employer Identification Number for Lixte Biotechnology
FAQ
What specific "Other Events" are being reported by Lixte Biotechnology?
The provided text snippet does not detail the specific "Other Events" being reported, only that this item is included in the 8-K filing.
What "Financial Statements and Exhibits" are included in this 8-K filing?
The provided text snippet indicates that "Financial Statements and Exhibits" are part of the filing, but does not list their specific contents.
What is the significance of the filing date February 25, 2025?
February 25, 2025, is the date of the earliest event reported and the date the 8-K form was filed with the SEC.
What is Lixte Biotechnology's principal executive office address?
Lixte Biotechnology's principal executive offices are located at 680 East Colorado Boulevard, Suite 180, Pasadena, California 91101.
What is Lixte Biotechnology's former company name?
Lixte Biotechnology's former company name was SRKP 7 INC, with a date of name change on August 3, 2005.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 25, 2025 regarding LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).